Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregnancy Outcome After Secondary Recurrent Pregnancy Loss (sRPL) is Influenced by Sex of the First Born Child and Maternal Carriage of HY-restricting HLA Class II Alleles

NCT05342948 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT05342948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05342948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregnancy Outcome After Secondary Recurrent Pregnancy Loss (sRPL) is Influenced by Sex of the First Born Child and Maternal Carriage of HY-restricting HLA Class II Alleles
Lead sponsor
Aalborg University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
October 1, 2022
Enrollment
583 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pregnancy loss